| | |
|---|---|
| **Protein Name** | Paraoxonase 2 |
| **Gene Symbol** | [PON2](/genes/pon2) |
| **UniProt ID** | [Q15165](https://www.uniprot.org/uniprot/Q15165) |
| **Molecular Weight** | ~39 kDa |
| **Subcellular Localization** | Endoplasmic Reticulum, Mitochondria, Cytoplasm |
| **Protein Family** | Paraoxonase family |
| **Tissue Expression** | Brain, Heart, Liver, Kidney |
| **Enzyme Activity** | Lactonase, Organophosphatase, Antioxidant |
Paraoxonase 2 (PON2) is a 39 kDa intracellular enzyme belonging to the paraoxonase family, which also includes PON1 and PON3. Unlike its family members, PON2 is not secreted and resides primarily in the endoplasmic reticulum and mitochondria, where it provides crucial cellular protection against oxidative stress. PON2 possesses lactonase, organophosphate-hydrolyzing, and antioxidant activities that make it a significant player in neuroprotection.
PON2 is widely expressed in human tissues, with high levels in the brain, heart, liver, and kidneys. In the nervous system, PON2 is expressed in both neurons and glial cells, where it protects against mitochondrial dysfunction, reduces reactive oxygen species (ROS), and inhibits apoptosis. Reduced PON2 expression and activity have been implicated in the pathogenesis of Alzheimer's Disease, Parkinson's Disease, and other neurodegenerative disorders.
¶ Structure and Enzyme Properties
PON2 shares structural homology with other paraoxonases, adopting a six-bladed beta-propeller fold characteristic of the family. However, PON2 has several unique features:
- Six-bladed beta-propeller: Catalytic core of the enzyme
- Unique N-terminus: Lacks the N-terminal signal peptide present in PON1/PON3, explaining intracellular localization
- Active site: Contains residues critical for lactonase and hydrolytic activity
- Calcium requirement: Enzyme activity requires calcium ions for structural stability and catalysis
- Lactonase activity: Hydrolyzes lactones including homocysteine thiolactone
- Organophosphatase activity: Hydrolyzes organophosphates and nerve agents
- Antioxidant activity: Prevents LDL oxidation and lipid peroxidation
PON2 plays a critical role in maintaining mitochondrial function:
- ROS reduction: PON2 inhibits mitochondrial ROS production by modulating Complex I activity
- Mitochondrial membrane potential: PON2 helps maintain mitochondrial membrane potential
- Apoptosis inhibition: PON2 prevents mitochondrial cytochrome c release and caspase activation
- Autophagy regulation: PON2 participates in mitophagy and mitochondrial quality control
In the ER, PON2:
- Reduces ER stress markers
- Modulates unfolded protein response (UPR)
- Protects against ER-associated degradation (ERAD) dysfunction
PON2 is upregulated under oxidative stress conditions:
- Heat shock response activates PON2 expression
- Nrf2 transcription factor regulates PON2
- Cellular antioxidant systems work synergistically with PON2
PON2 is increasingly recognized as important in AD pathogenesis:
-
Amyloid-beta toxicity: PON2 protects neurons from amyloid-beta-induced oxidative stress and cell death. Reduced PON2 makes neurons more vulnerable to Aβ toxicity.
-
Mitochondrial dysfunction: PON2 deficiency exacerbates mitochondrial dysfunction in AD, a hallmark of the disease. The protein helps maintain mitochondrial integrity.
-
Oxidative stress: AD brain shows elevated oxidative stress markers with corresponding reductions in PON2. The protein's antioxidant function is critical in countering this.
-
Tau pathology: PON2 may influence tau phosphorylation through its effects on mitochondrial function and cellular energetics.
-
Genetic associations: PON2 polymorphisms have been associated with AD risk in some populations.
In PD, PON2 plays protective roles:
-
Dopaminergic neuron survival: PON2 protects dopaminergic neurons from oxidative stress, which is particularly relevant given the high oxidative burden in these cells.
-
Mitochondrial complex I: PON2 modulates mitochondrial complex I activity, which is specifically impaired in PD.
-
Alpha-synuclein aggregation: PON2 may affect alpha-synuclein aggregation through its effects on cellular oxidative stress and protein quality control.
-
Neuroinflammation: PON2's anti-inflammatory properties may protect against glial activation in PD.
- PON2 is expressed in motor neurons
- Provides protection against oxidative stress-induced motor neuron death
- Altered expression in ALS patient tissues
- Huntington's Disease: PON2 may protect against mutant huntingtin-induced oxidative stress
- Multiple Sclerosis: PON2 expression altered in demyelinating lesions
- Friedreich's Ataxia: PON2 deficiency may contribute to mitochondrial dysfunction
PON2 represents a therapeutic target for neurodegenerative diseases:
- Upregulation strategies: Compounds that increase PON2 expression could provide neuroprotection
- Enzyme stabilization: Small molecules stabilizing PON2 activity
- Gene therapy: Viral vector delivery of PON2
- Antioxidant therapy: Enhancing overall cellular antioxidant capacity including PON2
- Statins: Some statins upregulate PON2 expression
- Polyphenols: Flavonoids and other polyphenols increase PON2
- Exercise: Physical activity upregulates PON2 in brain
- Calorie restriction: May enhance PON2 expression
PON2 interacts with:
- Mitochondrial proteins: Complex I components
- ER proteins: Calnexin, calreticulin
- Apolipoproteins: ApoE, ApoA-I
- Signaling molecules: Nrf2, p53